113 related articles for article (PubMed ID: 26106610)
1. HMGB1-Induced Cross Talk between PTEN and miRs 221/222 in Thyroid Cancer.
Mardente S; Mari E; Massimi I; Fico F; Faggioni A; Pulcinelli F; Antonaci A; Zicari A
Biomed Res Int; 2015; 2015():512027. PubMed ID: 26106610
[TBL] [Abstract][Full Text] [Related]
2. HMGB1 induces the overexpression of miR-222 and miR-221 and increases growth and motility in papillary thyroid cancer cells.
Mardente S; Mari E; Consorti F; Di Gioia C; Negri R; Etna M; Zicari A; Antonaci A
Oncol Rep; 2012 Dec; 28(6):2285-9. PubMed ID: 23023232
[TBL] [Abstract][Full Text] [Related]
3. Upregulation of miR-153 promotes cell proliferation via downregulation of the PTEN tumor suppressor gene in human prostate cancer.
Wu Z; He B; He J; Mao X
Prostate; 2013 May; 73(6):596-604. PubMed ID: 23060044
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-21 stimulates gastric cancer growth and invasion by inhibiting the tumor suppressor effects of programmed cell death protein 4 and phosphatase and tensin homolog.
Li L; Zhou L; Li Y; Lin S; Tomuleasa C
J BUON; 2014; 19(1):228-36. PubMed ID: 24659669
[TBL] [Abstract][Full Text] [Related]
5. MiR-142-3p functions as a potential tumor suppressor directly targeting HMGB1 in non-small-cell lung carcinoma.
Xiao P; Liu WL
Int J Clin Exp Pathol; 2015; 8(9):10800-7. PubMed ID: 26617792
[TBL] [Abstract][Full Text] [Related]
6. Silencing of the PTEN tumor-suppressor gene in anaplastic thyroid cancer.
Frisk T; Foukakis T; Dwight T; Lundberg J; Höög A; Wallin G; Eng C; Zedenius J; Larsson C
Genes Chromosomes Cancer; 2002 Sep; 35(1):74-80. PubMed ID: 12203792
[TBL] [Abstract][Full Text] [Related]
7. HMGB1 in cancer: good, bad, or both?
Kang R; Zhang Q; Zeh HJ; Lotze MT; Tang D
Clin Cancer Res; 2013 Aug; 19(15):4046-57. PubMed ID: 23723299
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of miR-21 promotes the proliferation and migration of cervical cancer cells via the inhibition of PTEN.
Xu J; Zhang W; Lv Q; Zhu D
Oncol Rep; 2015 Jun; 33(6):3108-16. PubMed ID: 25963606
[TBL] [Abstract][Full Text] [Related]
9. High mobility group box 1 is upregulated after spinal cord injury and is associated with neuronal cell apoptosis.
Kawabata H; Setoguchi T; Yone K; Souda M; Yoshida H; Kawahara K; Maruyama I; Komiya S
Spine (Phila Pa 1976); 2010 May; 35(11):1109-15. PubMed ID: 20195207
[TBL] [Abstract][Full Text] [Related]
10. [HMGB1--its role in tumor progression and anticancer therapy].
Smolarczyk R; Cichoń T; Jarosz M; Szala S
Postepy Hig Med Dosw (Online); 2012 Nov; 66():913-20. PubMed ID: 23175347
[TBL] [Abstract][Full Text] [Related]
11. Targeting high mobility group box protein 1 ameliorates testicular inflammation in experimental autoimmune orchitis.
Aslani F; Schuppe HC; Guazzone VA; Bhushan S; Wahle E; Lochnit G; Lustig L; Meinhardt A; Fijak M
Hum Reprod; 2015 Feb; 30(2):417-31. PubMed ID: 25452436
[TBL] [Abstract][Full Text] [Related]
12. Expression and clinical significance of HMGB1 in human liver cancer: Knockdown inhibits tumor growth and metastasis in vitro and in vivo.
Dong YD; Cui L; Peng CH; Cheng DF; Han BS; Huang F
Oncol Rep; 2013 Jan; 29(1):87-94. PubMed ID: 23042506
[TBL] [Abstract][Full Text] [Related]
13. Suppression of Elk1 inhibits thyroid cancer progression by mediating PTEN expression.
Kong Y; Yin J; Fu Y; Chen Y; Zhou Y; Geng X
Oncol Rep; 2018 Sep; 40(3):1769-1776. PubMed ID: 30015900
[TBL] [Abstract][Full Text] [Related]
14. High-mobility group box 1 (HMGB1) protein regulates tumor-associated cell migration through the interaction with BTB domain.
Ko YB; Kim BR; Nam SL; Yang JB; Park SY; Rho SB
Cell Signal; 2014 Apr; 26(4):777-83. PubMed ID: 24412753
[TBL] [Abstract][Full Text] [Related]
15. PTEN promoter methylation in sporadic thyroid carcinomas.
Alvarez-Nuñez F; Bussaglia E; Mauricio D; Ybarra J; Vilar M; Lerma E; de Leiva A; Matias-Guiu X;
Thyroid; 2006 Jan; 16(1):17-23. PubMed ID: 16487009
[TBL] [Abstract][Full Text] [Related]
16. PTEN expression is reduced in a subset of sporadic thyroid carcinomas: evidence that PTEN-growth suppressing activity in thyroid cancer cells mediated by p27kip1.
Bruni P; Boccia A; Baldassarre G; Trapasso F; Santoro M; Chiappetta G; Fusco A; Viglietto G
Oncogene; 2000 Jun; 19(28):3146-55. PubMed ID: 10918569
[TBL] [Abstract][Full Text] [Related]
17. Association of PTEN gene methylation with genetic alterations in the phosphatidylinositol 3-kinase/AKT signaling pathway in thyroid tumors.
Hou P; Ji M; Xing M
Cancer; 2008 Nov; 113(9):2440-7. PubMed ID: 18831514
[TBL] [Abstract][Full Text] [Related]
18. Ethyl pyruvate inhibits proliferation and induces apoptosis of hepatocellular carcinoma via regulation of the HMGB1-RAGE and AKT pathways.
Cheng P; Dai W; Wang F; Lu J; Shen M; Chen K; Li J; Zhang Y; Wang C; Yang J; Zhu R; Zhang H; Zheng Y; Guo CY; Xu L
Biochem Biophys Res Commun; 2014 Jan; 443(4):1162-8. PubMed ID: 24361892
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-200c inhibits apoptosis in pituitary adenoma cells by targeting the PTEN/Akt signaling pathway.
Liao C; Chen W; Fan X; Jiang X; Qiu L; Chen C; Zhu Y; Wang H
Oncol Res; 2013; 21(3):129-36. PubMed ID: 24512727
[TBL] [Abstract][Full Text] [Related]
20. Role of cell-cell interactions in high mobility group box 1 cytokine activity in human peripheral blood mononuclear cells and mouse splenocytes.
Kohka Takahashi H; Sadamori H; Liu K; Wake H; Mori S; Yoshino T; Yamamoto Y; Yamamoto H; Nishibori M
Eur J Pharmacol; 2013 Feb; 701(1-3):194-202. PubMed ID: 23228930
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
